GlobalData on MSN8 小时
Adaptimmune nears second sarcoma approval as Phase II trial hits endpoints
Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.
Protein Expression Market to Hit USD 4.82 Billion by 2029 with 7.1% CAGR | MarketsandMarkets™
The global protein expression market is expected to reach USD 4.82 billion in 2029 from USD 3.41 billion in 2024 at a CAGR of ...
Future Market Insights9 小时
Lab Automation Market is Projected to Grow Significantly USD 5.5 Billion by 2033 at a 10.1% ...
The global lab automation market is projected to grow significantly, with an estimated value of USD 2.1 billion in 2023 and ...